S1551 Efficacy and Safety of a Novel Investigational Hydrocortisone Acetate Suppository Formulation and Optimized Applicator for Treatment of Active Ulcerative Colitis: Results of the Phase 3 CESSA Trial
Year: 2025
Type: conference-abstract
Authors: Raj Devarajan, Philip Lavin, Mark Ensign, Jennifer Davagian
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7110931259
Cites:
Cited by:
Related to: